Amplia Therapeutics Ltd News

Amplia Therapeutics Ltd: Presentation and Webinar

Jun 11 08:30

Amplia Therapeutics Ltd: AACR Ovarian Cancer Conference Presentation

Oct 9, 2023 05:55

Amplia Therapeutics Ltd: AACR Pancreatic Cancer Conference Presentation

Sep 29, 2023 06:20

Amplia Therapeutics Ltd: Results of Annual General Meeting

Aug 24, 2023 09:58

Amplia Therapeutics Ltd: CEO and MD Presentation to Annual General Meeting

Aug 24, 2023 08:24

Amplia Therapeutics Ltd: Notice of Annual General Meeting/Proxy Form

Jul 21, 2023 14:58

Amplia Therapeutics Ltd: ATX - Shareholder Newsletter July 2023

Jul 20, 2023 07:52

Amplia Therapeutics Ltd: ATX - US Conference Presentation

Feb 23, 2023 13:55

Amplia Therapeutics Ltd: AmpliaTherapeutics - Lorne Cancer Conference Presentation

Feb 9, 2023 05:16

Amplia Therapeutics Ltd: Letter to Shareholders End of Year Summary and 2023 Plans

Dec 20, 2022 06:08

Amplia Therapeutics Ltd: Amplia Appoints Dr Christopher Burns CEO & Managing Director

Nov 7, 2022 05:47

Amplia Therapeutics Ltd: AACR Conference Presentation

Sep 14, 2022 06:06

Amplia Therapeutics Ltd: CEO Resignation

Sep 12, 2022 07:33

Amplia Therapeutics Ltd: Results of Annual General Meeting

Aug 25, 2022 10:06

Amplia Therapeutics Ltd: CEO & Managing Director Presentation to AGM

Aug 25, 2022 08:38

Amplia Therapeutics Ltd: Annual General Meeting - ESOP and New Constitution

Aug 17, 2022 06:15

Amplia Therapeutics Ltd: Notice of Annual General Meeting/Proxy - YE 31 March 2022

Jul 22, 2022 07:54

Amplia Therapeutics Ltd: Amplia Presentation to 16th Bioshares Biotech Summit

May 12, 2022 07:01

AMPLIA FPO: Sale of Unmarketable Parcels of Shares

Feb 14, 2022 09:27

Amplia Therapeutics Ltd: Amplia Investor Presentation - February 2022

Feb 1, 2022 05:21